IM4TB Overview

  • Founded
  • 2013


  • Status
  • Private

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $769K

  • Investors
  • 2

IM4TB General Information


Developer of faster-acting medicines designed to fight all forms of tuberculosis. The company's drug allows the treatment duration to be shortened and substantially diminishes the risks of failure of treatment, relapse of the disease, and increased prevalence of drug-resistance bacteria, enabling clinicians to provide a cure for tuberculosis disease in a pain-free way.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • EPFL Innovation Park
  • Building I
  • 1015 Lausanne
  • Switzerland
+41 021 000 00 00

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

IM4TB Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Grant 01-Sep-2022 $769K Completed Generating Revenue
2. Grant 16-Mar-2015 00000 Completed Startup
1. Accelerator/Incubator Completed Startup
To view IM4TB’s complete valuation and funding history, request access »

IM4TB Executive Team (1)

Name Title Board Seat Contact Info
Iain Old Ph.D Operational Director
To view IM4TB’s complete executive team members history, request access »

IM4TB Board Members (7)

Name Representing Role Since
Gabriel Clerc Self Vice Chairman of the Board 000 0000
Laurent Fraisse Ph.D Self Board Member 000 0000
Laurent Nicod MD Self Board Member 000 0000
Stewart Cole Self Chairman of the Board 000 0000
Thierry Buclin Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

IM4TB Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital 000 0000 000000 0
EPFL Innovation Park Accelerator/Incubator 000 0000 000000 0
To view IM4TB’s complete investors history, request access »